Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives

References

• Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin occasioned mystical experiences in the treatment of tobacco addiction. Curr Drug Abuse Rev. 2015;7:157–64. doi:10.2174/1874473708666150107121331.
   Google Scholar
• Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. 2014;28:983–92. doi:10.1177/0269881114548296.
   PubMed Web of Science ®Google Scholar
• Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PCR, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015;29:289–99. doi:10.1177/0269881114565144.
   PubMed Web of Science ®Google Scholar
• Krebs TS, Johansen PØ. Over 30 million psychedelic users in the United States. F1000Res. 2013;2:98. doi:10.12688/f1000research.2-98.v1.
   PubMedGoogle Scholar
• Albaugh BJ, Anderson PO. Peyote in the treatment of alcoholism among American Indians. Am J Psychiatry. 1974;131:1247–50. doi:10.1176/ajp.131.11.1247.
   PubMed Web of Science ®Google Scholar
• Fabregas JM, Gonzalez D, Fondevila S, Cutchet M, Fernandez X, Barbosa PCR, Alcázar-Córcoles MÁ, Barbanoj MJ, Riba J, Bouso JC, et al. Assessment of addiction severity among ritual users of ayahuasca. Drug Alcohol Depend. 2010;111:257–61.
   PubMed Web of Science ®Google Scholar
• Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30:1181–97.
   PubMed Web of Science ®Google Scholar
• Ross S. Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies. Psychiatr Clin North Am. 2012;35:357–74. doi:10.1016/j.psc.2012.04.002.
   PubMed Web of Science ®Google Scholar
• Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacol Ther. 2019;197:83–102. doi:10.1016/j.pharmthera.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Osmond H. A review of the clinical effects of psychotomimetic agents. Ann N Y Acad Sci. 1957;66:418–34. doi:10.1111/j.1749-6632.1957.tb40738.x.
   PubMed Web of Science ®Google Scholar
• Pahnke WN, Richards WA. Implications of LSD and experimental mysticism. J Relig Health. 1966;5:175–208. doi:10.1007/BF01532646.
   PubMedGoogle Scholar
• Savage C, McCabe OL. Residential psychedelic (LSD) therapy for the narcotic addict. A controlled study. Arch Gen Psychiatry. 1973;28:808–14. doi:10.1001/archpsyc.1973.01750360040005.
   PubMed Web of Science ®Google Scholar
• Bedi G, Cecchi GA, Slezak DF, Carrillo F, Sigman M, De Wit H. A window into the intoxicated mind? Speech as an index of psychoactive drug effects. Neuropsychopharmacology.2014;39:2340–48. doi:10.1038/npp.2014.80.
   PubMed Web of Science ®Google Scholar
• Johnson M, Richards W, Griffiths R. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 2008;22:603–20. doi:10.1177/0269881108093587.
   PubMed Web of Science ®Google Scholar
• Rice PL, Ezzy D. Qualitative research methods: a health focus. South Melbourne, VIC, Australia: OUP Australia; 2000.
   Google Scholar
• Sandelowski M. Telling stories: narrative approaches in qualitative research. Image J Nurs Sch. 1991;23:161–66. doi:10.1111/j.1547-5069.1991.tb00662.x.
   PubMedGoogle Scholar
• Atkinson P, Delamont S. Rescuing narrative from qualitative research. Narrat Inq. 2006;16:164–72. doi:10.1075/ni.16.1.21atk.
   Web of Science ®Google Scholar
• Cambria E, White B. Jumping NLP curves: a review of natural language processing research [review article]. IEEE Comput Intell Mag. 2014;9:48–57. doi:10.1109/MCI.2014.2307227.
   Web of Science ®Google Scholar
• Carrillo F, Mota N, Copelli M, Ribeiro S, Sigman M, Cecchi G, et al. Emotional intensity analysis in bipolar subjects [Internet]. arXiv [cs.AI]; 2016. Available from: http://arxiv.org/abs/1606.02231 [last accessed 4 Sep 2020].
   Google Scholar
• Carson NJ, Mullin B, Sanchez MJ, Lu F, Yang K, Menezes M, Cook BL. Identification of suicidal behavior among psychiatrically hospitalized adolescents using natural language processing and machine learning of electronic health records. PLoS One. 2019;14:e0211116.
   Google Scholar
• Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL. Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. J Affect Disord. 2018;230:84–86.
   PubMed Web of Science ®Google Scholar
• Coyle JR, Presti DE, Baggott MJ. Quantitative analysis of narrative reports of psychedelic drugs [Internet]. arXiv [q-bio.QM]; 2012. Available from: http://arxiv.org/abs/1206.0312 [last accessed 4 Sep 2020].
   Google Scholar
• Zamberlan F, Sanz C, Martínez Vivot R, Pallavicini C, Erowid F, Erowid E, Tagliazucchi E. The varieties of the psychedelic experience: a preliminary study of the association between the reported subjective effects and the binding affinity profiles of substituted phenethylamines and tryptamines. Front Integr Neurosci [Internet]. 2018;12. doi:10.3389/fnint.2018.00054.
   PubMed Web of Science ®Google Scholar
• Garcia-Romeu A, Griffiths RR, Johnson MW. Psychedelic-associated addiction remission: an online survey. Drug Alcohol Depend. 2017;171:e69. doi:10.1016/j.drugalcdep.2016.08.199.
   Web of Science ®Google Scholar
• Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. J Psychopharmacol. 2019;33:1088–101. doi:10.1177/0269881119845793.
   PubMed Web of Science ®Google Scholar
• Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. J Psychopharmacol. 2017;31:841–50. doi:10.1177/0269881116684335.
   PubMed Web of Science ®Google Scholar
• Loper E, Bird S. NLTK: the natural language toolkit [Internet]. arXiv [cs.CL]; 2002. Available from: http://arxiv.org/abs/cs/0205028 [last accessed 4 Sep 2020].
   Google Scholar
• Leskovec J, Rajaraman A, Ullman JD. Mining of massive datasets. 3rd ed. Cambridge, England: Cambridge University Press; 2020.
   Google Scholar
• Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in Python [Internet]. arXiv [cs.LG]; 2012. p. 2825–30.Available from: http://www.jmlr.org/papers/volume12/pedregosa11a/pedregosa11a.pdf [last accessed 23 Feb 2021].
   Google Scholar
• Deerwester S, Dumais ST, Furnas GW, Landauer TK, Harshman R. Indexing by latent semantic analysis. J Am Soc Inf Sci. 1990;41:391–407. doi:10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9.
   Web of Science ®Google Scholar
• Klema V, Laub A. The singular value decomposition: its computation and some applications. IEEE Trans Automat Contr. 1980;25:164–76. doi:10.1109/TAC.1980.1102314.
   Web of Science ®Google Scholar
• Field M, Mogg K, Mann B, Bennett GA, Bradley BP. Attentional biases in abstinent alcoholics and their association with craving. Psychol Addict Behav. 2013;27:71–80. doi:10.1037/a0029626.
   PubMed Web of Science ®Google Scholar
• Jajodia A, Earleywine M. Measuring alcohol expectancies with the implicit association test. Psychol Addict Behav. 2003;17:126–33. doi:10.1037/0893-164X.17.2.126.
   PubMed Web of Science ®Google Scholar
• Muller AC, Guido S. Introduction to machine learning with python: a guide for data scientists. Sebastopol (CA): O’Reilly Media; 2016.
   Google Scholar
• Connor JP, Gullo MJ, White A, Kelly AB. Polysubstance use: diagnostic challenges, patterns of use and health. Curr Opin Psychiatry. 2014;27:269–75. doi:10.1097/YCO.0000000000000069.
   PubMed Web of Science ®Google Scholar
• John WS, Zhu H, Mannelli P, Subramaniam GA, Schwartz RP, McNeely J, Wu L-T. Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco. Drug Alcohol Depend. 2019;194:468–75.
   PubMed Web of Science ®Google Scholar
• McCabe SE, West BT. The 3-year course of multiple substance use disorders in the United States: a national longitudinal study. J Clin Psychiatry. 2017;78:e537–44. doi:10.4088/JCP.16m10657.
   PubMed Web of Science ®Google Scholar
• Bogenschutz MP, Pommy JM. Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses: hallucinogens for addictions. Drug Test Anal. 2012;4:543–55. doi:10.1002/dta.1376.
   PubMed Web of Science ®Google Scholar
• Chwelos N, Blewett DB, Smith CM, Hoffer A. Use of d-lysergic acid diethylamide in the treatment of alcoholism. Q J Stud Alcohol. 1959;20:577–90. doi:10.15288/qjsa.1959.20.577.
   PubMedGoogle Scholar
• Grof S, Goodman LE, Richards WA, Kurland AA. LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry. 1973;8:129–44. doi:10.1159/000467984.
   PubMedGoogle Scholar
• Kurland AA, Grof S, Pahnke WN, Goodman LE. Psychedelic drug assisted psychotherapy. In: Goldberg IK, Malitz S, Kutscher AH, editors. Patients with terminal cancer psychotheramacological agents for the terminally ill and bereaved. New York: Columbia University Press; 1973. p. 86–133.
   Google Scholar
• Pisano VD, Putnam NP, Kramer HM, Franciotti KJ, Halpern JH, Holden SC. The association of psychedelic use and opioid use disorders among illicit users in the United States. J Psychopharmacol. 2017;31:606–13. doi:10.1177/0269881117691453.
   PubMed Web of Science ®Google Scholar
• Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse. 2017;43:55–60. doi:10.3109/00952990.2016.1170135.
   PubMed Web of Science ®Google Scholar
• Uthaug MV, Van Oorsouw K, Kuypers KPC, Van Boxtel M, Broers NJ, Mason NL, Toennes SW, Riba J, Ramaekers JG. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology (Berl). 2018;235:2979–89.
   PubMed Web of Science ®Google Scholar